{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:29:46Z","timestamp":1790785786690,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,10,13]],"date-time":"2017-10-13T00:00:00Z","timestamp":1507852800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Fogarty International Center and Office of Dietary Supplements of the National Institutes of Health","award":["D43 TW009118"],"award-info":[{"award-number":["D43 TW009118"]}]},{"name":"Fogarty International Center and Office of Dietary Supplements of the National Institutes of Health","award":["D43 TW009118"],"award-info":[{"award-number":["D43 TW009118"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1007\/s12020-017-1440-0","type":"journal-article","created":{"date-parts":[[2017,10,13]],"date-time":"2017-10-13T07:45:21Z","timestamp":1507880721000},"page":"39-49","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Effects of growth hormone therapy on bone density and fracture risk in age-related osteoporosis in the absence of growth hormone deficiency: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7891-7941","authenticated-orcid":false,"given":"Maya","family":"Barake","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asma","family":"Arabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Nakhoul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghada","family":"El-Hajj Fuleihan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"El Ghandour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Klibanski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas A.","family":"Tritos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,13]]},"reference":[{"issue":"6","key":"1440_CR1","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1210\/edrv.19.6.0353","volume":"19","author":"A Giustina","year":"1998","unstructured":"A. Giustina, J.D. Veldhuis, Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. Endocr. Rev. 19(6), 717\u2013797 (1998). \n                        https:\/\/doi.org\/10.1210\/edrv.19.6.0353","journal-title":"Endocr. Rev."},{"issue":"1","key":"1440_CR2","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1210\/edrv.19.1.0324","volume":"19","author":"C Ohlsson","year":"1998","unstructured":"C. Ohlsson, B.A. Bengtsson, O.G. Isaksson, T.T. Andreassen, M.C. Slootweg, Growth hormone and bone. Endocr. Rev. 19(1), 55\u201379 (1998). \n                        https:\/\/doi.org\/10.1210\/edrv.19.1.0324","journal-title":"Endocr. Rev."},{"issue":"2","key":"1440_CR3","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1210\/jcem.83.2.4594","volume":"83","author":"PV Carroll","year":"1998","unstructured":"P.V. Carroll, E.R. Christ, B.A. Bengtsson, L. Carlsson, J.S. Christiansen, D. Clemmons, R. Hintz, K. Ho, Z. Laron, P. Sizonenko, P.H. Sonksen, T. Tanaka, M. Thorne, Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Growth Hormone Research Society Scientific Committee. J. Clin. Endocrinol. Metab. 83(2), 382\u2013395 (1998). \n                        https:\/\/doi.org\/10.1210\/jcem.83.2.4594","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"1440_CR4","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1359\/jbmr.060112","volume":"21","author":"G Mazziotti","year":"2006","unstructured":"G. Mazziotti, A. Bianchi, S. Bonadonna, M. Nuzzo, V. Cimino, A. Fusco, L. De Marinis, A. Giustina, Increased prevalence of radiological spinal deformities in adult patients with GH deficiency: influence of GH replacement therapy. J. Bone Miner. Res. 21(4), 520\u2013528 (2006). \n                        https:\/\/doi.org\/10.1359\/jbmr.060112","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"1440_CR5","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s12020-015-0738-z","volume":"52","author":"G Mazziotti","year":"2016","unstructured":"G. Mazziotti, M. Doga, S. Frara, F. Maffezzoni, T. Porcelli, L. Cerri, R. Maroldi, A. Giustina, Incidence of morphometric vertebral fractures in adult patients with growth hormone deficiency. Endocrine 52(1), 103\u2013110 (2016). \n                        https:\/\/doi.org\/10.1007\/s12020-015-0738-z","journal-title":"Endocrine"},{"issue":"3","key":"1440_CR6","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1530\/eje.0.1370240","volume":"137","author":"T Rosen","year":"1997","unstructured":"T. Rosen, L. Wilhelmsen, K. Landin-Wilhelmsen, G. Lappas, B.A. Bengtsson, Increased fracture frequency in adult patients with hypopituitarism and GH deficiency. Eur. J. Endocrinol. 137(3), 240\u2013245 (1997)","journal-title":"Eur. J. Endocrinol."},{"issue":"2","key":"1440_CR7","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1359\/jbmr.2001.16.2.398","volume":"16","author":"C Wuster","year":"2001","unstructured":"C. Wuster, R. Abs, B.A. Bengtsson, H. Bennmarker, U. Feldt-Rasmussen, E. Hernberg-Stahl, J.P. Monson, B. Westberg, P. Wilton, K.S. Group, K.I.B.P. the; Upjohn International Metabolic, D., The influence of growth hormone deficiency, growth hormone replacement therapy, and other aspects of hypopituitarism on fracture rate and bone mineral density. J. Bone Miner. Res. 16(2), 398\u2013405 (2001). \n                        https:\/\/doi.org\/10.1359\/jbmr.2001.16.2.398","journal-title":"J. Bone Miner. Res."},{"issue":"3","key":"1440_CR8","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1210\/jc.2013-3921","volume":"99","author":"M Barake","year":"2014","unstructured":"M. Barake, A. Klibanski, N.A. Tritos, Effects of recombinant human growth hormone therapy on bone mineral density in adults with growth hormone deficiency: a meta-analysis. J. Clin. Endocrinol. Metab. 99(3), 852\u2013860 (2014). \n                        https:\/\/doi.org\/10.1210\/jc.2013-3921","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"1440_CR9","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0300-595X(84)80011-0","volume":"13","author":"DR Clemmons","year":"1984","unstructured":"D.R. Clemmons, J.J. Van Wyk, Factors controlling blood concentration of somatomedin C. Clin. Endocrinol. Metab. 13(1), 113\u2013143 (1984)","journal-title":"Clin. Endocrinol. Metab."},{"issue":"5","key":"1440_CR10","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1210\/jcem-73-5-1081","volume":"73","author":"A Iranmanesh","year":"1991","unstructured":"A. Iranmanesh, G. Lizarralde, J.D. Veldhuis, Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men. J. Clin. Endocrinol. Metab. 73(5), 1081\u20131088 (1991). \n                        https:\/\/doi.org\/10.1210\/jcem-73-5-1081","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"1440_CR11","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1210\/jcem-60-3-513","volume":"60","author":"Z Zadik","year":"1985","unstructured":"Z. Zadik, S.A. Chalew, R.J. McCarter Jr., M. Meistas, A.A. Kowarski, The influence of age on the 24-hour integrated concentration of growth hormone in normal individuals. J Clin Endocrinol Metab 60(3), 513\u2013516 (1985). \n                        https:\/\/doi.org\/10.1210\/jcem-60-3-513","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1440_CR12","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1365-2796.1992.tb00550.x","volume":"232","author":"S Ljunghall","year":"1992","unstructured":"S. Ljunghall, A.G. Johansson, P. Burman, O. Kampe, E. Lindh, F.A. Karlsson, Low plasma levels of insulin-like growth factor 1 (IGF-1) in male patients with idiopathic osteoporosis. J. Intern. Med. 232(1), 59\u201364 (1992)","journal-title":"J. Intern. Med."},{"issue":"6","key":"1440_CR13","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1046\/j.1365-2265.2001.01390.x","volume":"55","author":"M Munoz-Torres","year":"2001","unstructured":"M. Munoz-Torres, P. Mezquita-Raya, F. Lopez-Rodriguez, E. Torres-Vela, J. de Dios Luna, F. Escobar-Jimenez, The contribution of IGF-I to skeletal integrity in postmenopausal women. Clin. Endocrinol. 55(6), 759\u2013766 (2001)","journal-title":"Clin. Endocrinol."},{"issue":"9207","key":"1440_CR14","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/S0140-6736(99)05463-X","volume":"355","author":"P Garnero","year":"2000","unstructured":"P. Garnero, E. Sornay-Rendu, P.D. Delmas, Low serum IGF-1 and occurrence of osteoporotic fractures in postmenopausal women. Lancet 355(9207), 898\u2013899 (2000)","journal-title":"Lancet"},{"issue":"4","key":"1440_CR15","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1002\/jbmr.281","volume":"26","author":"C Ohlsson","year":"2011","unstructured":"C. Ohlsson, D. Mellstrom, D. Carlzon, E. Orwoll, O. Ljunggren, M.K. Karlsson, L. Vandenput, Older men with low serum IGF-1 have an increased risk of incident fractures: the MrOS Sweden study. J. Bone Miner. Res. 26(4), 865\u2013872 (2011). \n                        https:\/\/doi.org\/10.1002\/jbmr.281","journal-title":"J. Bone Miner. Res."},{"issue":"3","key":"1440_CR16","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1359\/jbmr.2003.18.3.393","volume":"18","author":"K Landin-Wilhelmsen","year":"2003","unstructured":"K. Landin-Wilhelmsen, A. Nilsson, I. Bosaeus, B.A. Bengtsson, Growth hormone increases bone mineral content in postmenopausal osteoporosis: a randomized placebo-controlled trial. J. Bone Miner. Res. 18(3), 393\u2013405 (2003). \n                        https:\/\/doi.org\/10.1359\/jbmr.2003.18.3.393","journal-title":"J. Bone Miner. Res."},{"issue":"5","key":"1440_CR17","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1530\/eje.0.1400390","volume":"140","author":"M Saaf","year":"1999","unstructured":"M. Saaf, A. Hilding, M. Thoren, S. Troell, K. Hall, Growth hormone treatment of osteoporotic postmenopausal women - a one-year placebo-controlled study. Eur. J. Endocrinol. 140(5), 390\u2013399 (1999)","journal-title":"Eur. J. Endocrinol."},{"issue":"3-4","key":"1440_CR18","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.ghir.2012.03.002","volume":"22","author":"S Yang","year":"2012","unstructured":"S. Yang, L. Cao, S. Cai, J. Yuan, J. Wang, A systematic review of growth hormone for hip fractures. Growth Horm. IGF Res. 22(3-4), 97\u2013101 (2012). \n                        https:\/\/doi.org\/10.1016\/j.ghir.2012.03.002","journal-title":"Growth Horm. IGF Res."},{"issue":"2","key":"1440_CR19","doi-asserted-by":"crossref","first-page":"104","DOI":"10.7326\/0003-4819-146-2-200701160-00005","volume":"146","author":"H Liu","year":"2007","unstructured":"H. Liu, D.M. Bravata, I. Olkin, S. Nayak, B. Roberts, A.M. Garber, A.R. Hoffman, Systematic review: the safety and efficacy of growth hormone in the healthy elderly. Ann. Intern. Med. 146(2), 104\u2013115 (2007)","journal-title":"Ann. Intern. Med."},{"issue":"1","key":"1440_CR20","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1017\/S0714980816000696","volume":"36","author":"HF Atkinson","year":"2017","unstructured":"H.F. Atkinson, R.F. Moyer, D. Yacoub, D. Coughlin, T.B. Birmingham, Effects of recombinant human growth hormone for osteoporosis: systematic review and meta-analysis. Can. J. Aging 36(1), 41\u201354 (2017). \n                        https:\/\/doi.org\/10.1017\/S0714980816000696","journal-title":"Can. J. Aging"},{"issue":"6","key":"1440_CR21","first-page":"1222","volume":"24","author":"A Cranney","year":"1997","unstructured":"A. Cranney, P. Tugwell, S. Cummings, P. Sambrook, J. Adachi, A.J. Silman, W.J. Gillespie, D.T. Felson, B. Shea, G. Wells, Osteoporosis clinical trials endpoints: candidate variables and clinimetric properties. J. Rheumatol. 24(6), 1222\u20131229 (1997)","journal-title":"J. Rheumatol."},{"key":"1440_CR22","unstructured":"COMET: initiative. \n                        www.comet-initiative.org\n                        \n                    . Accessed in January 2016"},{"issue":"5","key":"1440_CR23","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1365-2265.1995.tb02920.x","volume":"43","author":"RJ Erdtsieck","year":"1995","unstructured":"R.J. Erdtsieck, H.A. Pols, N.K. Valk, B.M. van Ouwerkerk, S.W. Lamberts, P. Mulder, J.C. Birkenhager, Treatment of post-menopausal osteoporosis with a combination of growth hormone and pamidronate: a placebo controlled trial. Clin. Endocrinol. 43(5), 557\u2013565 (1995)","journal-title":"Clin. Endocrinol."},{"issue":"4","key":"1440_CR24","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1210\/jcem.82.4.3901","volume":"82","author":"L Holloway","year":"1997","unstructured":"L. Holloway, L. Kohlmeier, K. Kent, R. Marcus, Skeletal effects of cyclic recombinant human growth hormone and salmon calcitonin in osteopenic postmenopausal women. J. Clin. Endocrinol. Metab. 82(4), 1111\u20131117 (1997). \n                        https:\/\/doi.org\/10.1210\/jcem.82.4.3901","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9","key":"1440_CR25","doi-asserted-by":"publisher","first-page":"3251","DOI":"10.1210\/jc.2015-1757","volume":"100","author":"E Krantz","year":"2015","unstructured":"E. Krantz, P. Trimpou, K. Landin-Wilhelmsen, Effect of growth hormone treatment on fractures and quality of life in postmenopausal osteoporosis: a 10-year follow-up study. J. Clin. Endocrinol. Metab. 100(9), 3251\u20133259 (2015). \n                        https:\/\/doi.org\/10.1210\/jc.2015-1757","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1440_CR26","unstructured":"J.P.T. Higgins, S. Green, Cochrane handbook for systematic reviews of interventions. version 5.1.0. The Cochrane Collaboration (2011)"},{"issue":"1","key":"1440_CR27","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1046\/j.1365-2265.1997.d01-1750.x","volume":"46","author":"S Gonnelli","year":"1997","unstructured":"S. Gonnelli, C. Cepollaro, M. Montomoli, L. Gennari, A. Montagnani, R. Palmieri, C. Gennari, Treatment of post-menopausal osteoporosis with recombinant human growth hormone and salmon calcitonin: a placebo controlled study. Clin. Endocrinol. 46(1), 55\u201361 (1997)","journal-title":"Clin. Endocrinol."},{"issue":"2","key":"1440_CR28","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/0026-0495(85)90120-9","volume":"34","author":"JF Aloia","year":"1985","unstructured":"J.F. Aloia, A. Vaswani, A. Kapoor, J.K. Yeh, S.H. Cohn, Treatment of osteoporosis with calcitonin, with and without growth hormone. Metabolism 34(2), 124\u2013129 (1985)","journal-title":"Metabolism"},{"issue":"5","key":"1440_CR29","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/BF02555257","volume":"40","author":"JF Aloia","year":"1987","unstructured":"J.F. Aloia, A. Vaswani, P.J. Meunier, C.M. Edouard, M.E. Arlot, J.K. Yeh, S.H. Cohn, Coherence treatment of postmenopausal osteoporosis with growth hormone and calcitonin. Calcif. Tissue Int. 40(5), 253\u2013259 (1987)","journal-title":"Calcif. Tissue Int."},{"issue":"9","key":"1440_CR30","doi-asserted-by":"publisher","first-page":"3352","DOI":"10.1210\/jcem.81.9.8784096","volume":"81","author":"TB Hansen","year":"1996","unstructured":"T.B. Hansen, K. Brixen, N. Vahl, J.O. Jorgensen, J.S. Christiansen, L. Mosekilde, C. Hagen, Effects of 12 months of growth hormone (GH) treatment on calciotropic hormones, calcium homeostasis, and bone metabolism in adults with acquired GH deficiency: a double blind, randomized, placebo-controlled study. J. Clin. Endocrinol. Metab. 81(9), 3352\u20133359 (1996). \n                        https:\/\/doi.org\/10.1210\/jcem.81.9.8784096","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1440_CR31","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1146\/annurev.me.38.020187.001021","volume":"38","author":"R Marcus","year":"1987","unstructured":"R. Marcus, Normal and abnormal bone remodeling in man. Annu. Rev. Med. 38, 129\u2013141 (1987). \n                        https:\/\/doi.org\/10.1146\/annurev.me.38.020187.001021","journal-title":"Annu. Rev. Med."},{"issue":"11","key":"1440_CR32","doi-asserted-by":"publisher","first-page":"4900","DOI":"10.1210\/jc.2002-020231","volume":"87","author":"P Gillberg","year":"2002","unstructured":"P. Gillberg, H. Mallmin, M. Petren-Mallmin, S. Ljunghall, A.G. Nilsson, Two years of treatment with recombinant human growth hormone increases bone mineral density in men with idiopathic osteoporosis. J. Clin. Endocrinol. Metab. 87(11), 4900\u20134906 (2002). \n                        https:\/\/doi.org\/10.1210\/jc.2002-020231","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"1440_CR33","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1210\/jc.2011-0179","volume":"96","author":"ME Molitch","year":"2011","unstructured":"M.E. Molitch, D.R. Clemmons, S. Malozowski, G.R. Merriam, M.L. Vance, S. Endocrine, Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 96(6), 1587\u20131609 (2011). \n                        https:\/\/doi.org\/10.1210\/jc.2011-0179","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"13","key":"1440_CR34","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1056\/NEJMoa035725","volume":"349","author":"JS Finkelstein","year":"2003","unstructured":"J.S. Finkelstein, A. Hayes, J.L. Hunzelman, J.J. Wyland, H. Lee, R.M. Neer, The effects of parathyroid hormone, alendronate, or both in men with osteoporosis. N. Engl. J. Med. 349(13), 1216\u20131226 (2003). \n                        https:\/\/doi.org\/10.1056\/NEJMoa035725","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"1440_CR35","doi-asserted-by":"publisher","first-page":"P1","DOI":"10.1530\/EJE-15-0873","volume":"174","author":"DB Allen","year":"2016","unstructured":"D.B. Allen, P. Backeljauw, M. Bidlingmaier, B.M. Biller, M. Boguszewski, P. Burman, G. Butler, K. Chihara, J. Christiansen, S. Cianfarani, P. Clayton, D. Clemmons, P. Cohen, F. Darendeliler, C. Deal, D. Dunger, E.M. Erfurth, J.S. Fuqua, A. Grimberg, M. Haymond, C. Higham, K. Ho, A.R. Hoffman, A. Hokken-Koelega, G. Johannsson, A. Juul, J. Kopchick, P. Lee, M. Pollak, S. Radovick, L. Robison, R. Rosenfeld, R.J. Ross, L. Savendahl, P. Saenger, H. Toft Sorensen, K. Stochholm, C. Strasburger, A. Swerdlow, M. Thorner, GH safety workshop position paper: a critical appraisal of recombinant human GH therapy in children and adults. Eur. J. Endocrinol. 174(2), P1\u20139 (2016). \n                        https:\/\/doi.org\/10.1530\/EJE-15-0873","journal-title":"Eur. J. Endocrinol."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-017-1440-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-017-1440-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-017-1440-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,3,27]],"date-time":"2018-03-27T04:20:02Z","timestamp":1522124402000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-017-1440-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,13]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["1440"],"URL":"https:\/\/doi.org\/10.1007\/s12020-017-1440-0","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,13]]}}}